Site-saturation functional screens identify PALB2 missense variants associated with increased breast cancer risk

Journal:

Nature Communications

Published:

2026-01-19

DOI:

10.1038/s41467-025-67252-z

Affiliations:

28

Authors:

61

Go to article

Institutions	Authors	Share
Leiden University Medical Center (LUMC), Netherlands	10.000000 10.000000	0.16
Institute of Medical Biochemistry and Laboratory Diagnostics, Czech Republic	8.333333	0.14
GHC Genetics, Czech Republic	5.000000	0.08
University Hospital Pilsen, Czech Republic	5.000000	0.08
Mayo Clinic, United States of America (USA)	3.000000	0.05
GENNET Archa, Czech Republic	3.000000	0.05
University Hospital Olomouc, PU, Czech Republic	3.000000	0.05
PRENET - Laboratore Lekarske Genetiky, Czech Republic	3.000000	0.05
Charles University (CU), Czech Republic	2.333333	0.04
General University Hospital in Prague, Czech Republic	2.333333	0.04
Bio-Prodict BV, Netherlands	2.000000	0.03
Ambry Genetics, United States of America (USA)	2.000000	0.03
Masaryk Memorial Cancer Institute (MMCI), Czech Republic	2.000000	0.03
AGEL Group, Czech Republic	2.000000	0.03
Pronatal, Czech Republic	2.000000	0.03
Hospital České Budějovice, Czech Republic	2.000000	0.03
Memorial Sloan Kettering Cancer Center (MSKCC), United States of America (USA)	1.500000	0.02
University Hospital Ostrava, OSU, Czech Republic	1.000000	0.02
Genetika Plzeň, Czech Republic	1.000000	0.02
Weill Cornell Medicine, United States of America (USA)	0.500000	0.01

Interested in Oncology and Carcinogenesis?